[Code of Federal Regulations]
[Title 49, Volume 3]
[Revised as of October1, 2002]
From the U.S. Government Printing Office via GPO Access
[CITE: 49CFR199.119]

[Page 188]
 
                        TITLE 49--TRANSPORTATION
 
 CHAPTER I--RESEARCH AND SPECIAL PROGRAMS ADMINISTRATION, DEPARTMENT OF 
                       TRANSPORTATION (CONTINUED)
 
PART 199--DRUG AND ALCOHOL TESTING--Table of Contents
 
                         Subpart B--Drug Testing
 
Sec. 199.119  Reporting of anti-drug testing results.

    (a) Each large operator (having more than 50 covered employees) 
shall submit an annual MIS report to RSPA of its anti-drug testing 
results in the form and manner prescribed by the Administrator, not 
later than March 15 of each year for the prior calendar year (January 1 
through December 31). The Administrator shall require by written notice 
that small operators (50 or fewer covered employees) not otherwise 
required to submit annual MIS reports to prepare and submit such reports 
to RSPA.
    (b) Each report, required under this section, shall be submitted to 
the Office of Pipeline Safety Compliance (OPS), Research and Special 
Programs Administration, Department of Transportation, room 2335, 400 
Seventh Street, SW., Washington, DC 20590.
    (c) Each report shall be submitted in the form and manner prescribed 
by the Administrator. No other form, including another DOT Operating 
Administration's MIS form, is acceptable for submission to RSPA.
    (d) Each report shall be signed by the Operator's anti-drug manager 
or designated representative. RSPA will allow the operator the option of 
sending the report on the computer disk provided by RSPA. If this option 
is used, a signature page attesting to the validity of the information 
on the computer disk must be sent to the address in paragraph (b) of 
this section.
    (e) Each operator's report with verified positive test results or 
refusals to test shall include all of the following informational 
elements:
    (1) Number of covered employees.
    (2) Number of covered employees subject to testing under the anti-
drug rules of another operating administration.
    (3) Number of specimens collected by type of test.
    (4) Number of positive test results, verified by a Medical Review 
Officer (MRO), by type of test and type of drug.
    (5) Number of employee action(s) taken following verified 
positive(s), by type of action(s).
    (6) Number of negative tests reported by an MRO by type of test.
    (7) Number of persons denied a position as a covered employee 
following a verified positive drug test.
    (8) Number of covered employees, returned to duty during this 
reporting period after having failed or refused a drug test required 
under the RSPA rule.
    (9) Number of covered employees with tests verified positive by an 
MRO for multiple drugs.
    (10) Number of covered employees who refused to submit to a random 
or non-random (post-accident, reasonable cause, return-to- duty, or 
follow-up) drug test and the action taken in response to each refusal.
    (11) Number of supervisors who have received required initial 
training during the reporting period.
    (f) Each operator's report with only negative test results shall 
include all of the following informational elements:
    (1) Number of covered employees.
    (2) Number of covered employees subject to testing under the anti-
drug rules of another operating administration.
    (3) Number of specimens collected by type of test.
    (4) Number of negative tests reported by an MRO by type of test.
    (5) Number of covered employees who refused to submit to a random or 
non-random (post-accident, reasonable cause, return-to-duty, or follow-
up) drug test and the action taken in response to each refusal.
    (6) Number of supervisors who have received required initial 
training during the reporting period.

[58 FR 68261, Dec. 23, 1993, as amended by Amdt. 199-14, 61 FR 65365, 
Dec. 12, 1996. Redesignated by Amdt. 199-19, 66 FR 47118, Sept. 11, 
2001]

[[Page 189]]